An Ann Arbor-based startup saw the largest fundraise in the state, with the close of a $51 million Series B round. The $119 ...

For patients with relapsed/refractory large B-cell lymphoma, access to lifesaving CD19-directed chimeric antigen receptor (CAR) T-cell therapy may be limited by post-infusion monitoring protocols ...

An American Society of Radiation Oncology survey has shined a spotlight on the impact prior authorization has on providers and patients. Adjuvant cemiplimab prolonged DFS compared with placebo for ...

Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next year, with key trial readouts expected from companies including Moderna ...

Elahere was approved for FRα-positive, platinum-resistant gynecologic cancers, showing better outcomes than chemotherapy in the MIRASOL trial. Udenyca's on-body administration offers a new method for ...

After hours: January 17 at 7:45:45 PM EST ...

AstraZeneca: Head of Clinical Operations for the Cell Therapy Solid Tumor portfolio ...

1 Division of Preventive Oncology, ICMR - National Institute of Cancer Prevention and Research, Noida, India 2 ICMR - National Institute of Medical Statistics, New Delhi, India 3 ICMR - National ...